inositol niacinate has been researched along with niacin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (93.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BERGE, T; JOHANSEN, E | 1 |
| KAPPERT, A | 1 |
| EDE, M; WELSH, AL | 1 |
| ANNINO, G; BRANZI, G | 1 |
| KABESHIMA, A; NAKAHARA, M; NAKAZAWA, T; SAITO, M; UUCHI, Y | 1 |
| MIYABE, I; SUZUKI, Y | 1 |
| HANADA, M; OKADA, Y; SUGIURA, Y | 1 |
| CHITI, W | 1 |
| GIOSEFFI, G; PAGLIANI, P | 1 |
| LIOTTA, S | 1 |
| PISKORZ, A | 1 |
| HAMILTON, RR | 1 |
| BLYN, C; LUMISH, SH; NODINE, JH | 1 |
| LOSCALZO, B; MARMO, E; MIELE, E; PREZIOSI, P | 1 |
| Chow, DS; Liang, D; Poon, IO | 1 |
15 other study(ies) available for inositol niacinate and niacin
| Article | Year |
|---|---|
[Hexanicit in arterial insufficiency of the lower extremities].
Topics: Humans; Lower Extremity; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases | 1958 |
[Experimental and clinico-therapeutic research with Hexanicit].
Topics: Humans; Inositol; Niacin; Nicotinic Acids; Therapeutic Human Experimentation | 1961 |
Inositol hexanicotinate for improved nicotinic acid therapy. Preliminary report.
Topics: Humans; Inositol; Niacin; Nicotinic Acids | 1961 |
[Therapy of peripheral arteriopathies with a compound with a base of inositol hexanicotinate].
Topics: Inositol; Niacin; Nicotinic Acids; Peripheral Arterial Disease; Peripheral Vascular Diseases; Pyridoxine; Vascular Diseases; Vasodilator Agents | 1963 |
[CLINICAL TRIAL OF A NEW NICOTINIC ACID DERIVATIVE, MESO-INOSITOL-HEXANICOTINATE, IN NEUROPSYCHIATRY].
Topics: Autonomic Nervous System Diseases; Cerebrovascular Disorders; Inositol; Neuritis; Neuropsychiatry; Niacin; Nicotinic Acids | 1963 |
[CLINICAL TRIAL OF HEXANICIT TABLETS IN TINNITUS].
Topics: Humans; Japan; Niacin; Nicotinic Acids; Tablets; Tinnitus | 1963 |
[CLINICAL TESTING OF MESO-INOSITOL-HEXANICOTINATE].
Topics: Cerebrovascular Disorders; Craniocerebral Trauma; Inositol; Niacin; Nicotinic Acids; Vascular Diseases | 1963 |
[APROPOS OF THE GASTROINTESTINAL ABSORPTION OF INOSITOL HEXANICOTINATE].
Topics: Absorption; Gastrointestinal Absorption; Gastrointestinal Tract; Humans; Inositol; Intestinal Absorption; Metabolism; Niacin; Nicotinic Acids | 1964 |
[PHARMACOLOGICAL EXPERIMENTS WITH A COMBINATION OF KALLIKREIN AND MESO-INOSITOL HEXANICOTINATE].
Topics: Blood Pressure; Blood Pressure Determination; Blood Vessels; Coronary Vessels; Inositol; Kallikreins; Liver Diseases; Mice; Niacin; Nicotinic Acids; Pharmacology; Rats; Research; Toxicology | 1964 |
[FIRST EXPERIENCES ON THE THERAPEUTIC ACTIVITY OF M-INOSITOL HEXANICOTINATE AND KALLIKREIN IN PERIPHERAL VASCULAR DISEASES AND IN CORONARY DISEASE].
Topics: Coronary Disease; Electric Impedance; Electrocardiography; Humans; Kallikreins; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Plethysmography; Plethysmography, Impedance; Vascular Diseases | 1964 |
[TREATMENT OF ISCHEMIC DISTURBANCES WITHIN EXTREMITIES BY MEANS OF HEXOPAL ADMINISTRATION].
Topics: Drug Therapy; Inositol; Ischemia; Niacin; Nicotinic Acids; Vascular Diseases | 1965 |
Speripheral vascular disease in general practice. Some experiences with meso-inositol-hexanicotinate.
Topics: General Practice; Inositol; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Vascular Diseases; Vasodilator Agents | 1960 |
Inositol niacinate as a peripheral vasodilator.
Topics: Arteriosclerosis; Cardiovascular Agents; Humans; Inositol; Niacin; Nicotinic Acids; Vasodilator Agents | 1962 |
[Apropos of the hypocholesterolemic effects of nicotinic acid. Experimental investigations of such a compound and of inositol hexanicotinate].
Topics: Cholesterol; Inositol; Niacin; Nicotinic Acids | 1961 |
Dissolution profiles of nonprescription extended-release niacin and inositol niacinate products.
Topics: Delayed-Action Preparations; Humans; Hypolipidemic Agents; In Vitro Techniques; Niacin; Nicotinic Acids; Nonprescription Drugs; Solubility; United States | 2006 |